Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin

The purpose of this study was to evaluate by a retrospective analysis of 53 patients the efficacy of chemotherapy combining etoposide and cisplatin in the treatment of neuroendocrine tumours. The regimen was a combination of etoposide 100 mg m(–2) day(–1) for 3 days and cisplatin 100 mg m(–2) on day...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitry, E, Baudin, E, Ducreux, M, Sabourin, J-C, Rufié, P, Aparicio, T, Lasser, P, Elias, D, Duvillard, P, Schlumberger, M, Rougier, P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362979/
https://www.ncbi.nlm.nih.gov/pubmed/10604732
http://dx.doi.org/10.1038/sj.bjc.6690325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362979/
https://www.ncbi.nlm.nih.gov/pubmed/10604732
http://dx.doi.org/10.1038/sj.bjc.6690325

Ejemplares similares